Cargando…

Evolution in the management of non-small cell lung cancer in Brazil

Detalles Bibliográficos
Autor principal:	Fernandes, Caio Júlio Cesar dos Santos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792035/ https://www.ncbi.nlm.nih.gov/pubmed/29340484 http://dx.doi.org/10.1590/S1806-37562017000060002

Ejemplares similares

Robotic thoracic surgery for non-small cell lung cancer: initial experience in Brazil
por: Terra, Ricardo Mingarini, et al.
Publicado: (2020)

Brazil and the COVID-19 Pandemic
por: Soares dos Santos Junior, Augusto Cesar
Publicado: (2021)

Multiple layers of intratumor heterogeneity: clues to clonal evolution of non-small cell lung cancer
por: Dietz, Steffen, et al.
Publicado: (2019)

Critical points in the management of EGFR-mutated non-small cell lung cancer
por: Casaluce, Francesca, et al.
Publicado: (2022)

Postoperative management for non-small cell lung cancer harboring EGFR mutations
por: Tanaka, Fumihiro, et al.
Publicado: (2020)

Should all COVID-19 patients be approached in the same way?
por: Fernandes, Caio Julio Cesar dos Santos
Publicado: (2020)

Realities of KRAS-mutated non-small cell lung cancer
por: Min, Young Joo
Publicado: (2017)

Immunotherapy in non-small cell lung cancer: advancements and challenges
por: Zhou, Fei, et al.
Publicado: (2021)

Resectable non-small cell lung cancer: an evolving landscape
por: Loh, Jerold, et al.
Publicado: (2022)

The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer
por: Almquist, Daniel R., et al.
Publicado: (2021)

The more we learn, the more there is to know: the clinical management of stage I non-small cell lung cancer
por: Engelhardt, Kathryn E., et al.
Publicado: (2022)

Molecular profile of non-small cell lung cancer in northeastern Brazil
por: de Oliveira, Ana Claudia da Silva Mendes, et al.
Publicado: (2019)

Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer
por: Mamdani, Hirva, et al.
Publicado: (2017)

Histology Matters: Individualizing Treatment in Non-Small Cell Lung Cancer
por: Neal, Joel W.
Publicado: (2010)

Functions of metabolic enzymes in the development of non‐small cell lung cancer
por: Zhao, Gang
Publicado: (2019)

Immunotherapy in non‐small cell lung cancer: The past, the present, and the future
por: Lu, Meng, et al.
Publicado: (2019)

Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside
por: de Mello, Ramon Andrade, et al.
Publicado: (2020)

Identifying successful biomarkers for patients with non-small-cell lung cancer
por: Friedlaender, Alex, et al.
Publicado: (2019)

Treatment strategy of EGFR-mutated non-small cell lung cancer
por: Tanaka, Fumihiro, et al.
Publicado: (2022)

Immunotherapy as a targeted therapy in non-small cell lung cancer
por: Rocco, Danilo, et al.
Publicado: (2019)

Surgery for Non-Small Cell Lung Cancer in the Personalized Therapy Era
por: Chiappetta, Marco, et al.
Publicado: (2023)

The Evolution of Therapies in Non-Small Cell Lung Cancer
por: Boolell, Vishal, et al.
Publicado: (2015)

Tumor evolution in non-small-cell lung cancer
por: Parry, Marina
Publicado: (2018)

Lung cancer staging in Brazil: an epidemiological perspective
por: Franceschini, Juliana Pereira, et al.
Publicado: (2020)

First-line management of advanced non-small-cell lung cancer: can we do better?
por: Chouaïd, Christos, et al.
Publicado: (2023)

Biomarkers predictive value in early stage non-small cell lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2020)

Biopsy and rebiopsy for non-small-cell lung cancer: current and future methods
por: Zarogoulidis, Paul, et al.
Publicado: (2019)

Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence
por: Cao, Christopher, et al.
Publicado: (2020)

Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint
por: Faltermeier, Claire M., et al.
Publicado: (2021)

Expert consensus on perioperative immunotherapy in non-small cell lung cancer: an editorial
por: Facchinetti, Francesco, et al.
Publicado: (2021)

Diagnosis and treatment of non-small cell lung cancer: current advances and challenges
por: Diebels, Ian, et al.
Publicado: (2022)

Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision Medicine
por: Pons-Tostivint, Elvire, et al.
Publicado: (2022)

TTF-1 and immune checkpoint therapy in non-small cell lung cancer
por: Gumbleton, Matthew, et al.
Publicado: (2023)

Surgery for stage IV non-small cell lung cancer?
por: Puig, Carlos A., et al.
Publicado: (2020)

The Evolution of BRAF Activation in Non-Small-Cell Lung Cancer
por: Zhang, Longyao, et al.
Publicado: (2022)

The evolution of non-small cell lung cancer metastases in TRACERx
por: Al Bakir, Maise, et al.
Publicado: (2023)

Management of brain metastases in non-small cell lung cancer without actionable driver mutations—the need to dive deeper in the right ‘pool’
por: Jablonska, Paola Anna, et al.
Publicado: (2023)

Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer
por: Lu, Ying-Qiang, et al.
Publicado: (2017)

Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer
por: Alifano, Marco
Publicado: (2020)

Patient-reported outcome measures in definitive chemoradiation for non-small cell lung cancer
por: Voong, Khinh Ranh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ckvl3rv4q05nel7qof9lf5ge5g